Home Featured 2

Featured 2

Featured posts

Random

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

lungcanc

Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s Perspective

TTFields in Mesothelioma (The STELLAR Trial): More Stars Needed in the Constellation

Journal Radar: Robust Survival Duration Shown in NSCLC With Pembrolizumab

Sublobar Resections for Early Lung Cancer

Telehealth: Bridging the Digital Divide Is Still a Work In Progress

lungcanc

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

lungcanc

Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

lungcanc

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

lungcanc

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

lungcanc

2019 IASLC Best of the World Lung Cancer Conference Results in...

lungcanc

Financial Incentives and Free Treatment Aids for Smoking Cessation in the...

lungcanc

Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

lungcanc

Dr. Jamie E. Chaft Discusses Emerging Data on Induction Immunotherapy for...

lungcanc

Expanding Efforts Help Address Disparities in Lung Cancer Care

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib